Structural Heart Procedures

Left Atrial Appendage Occlusion

The Left Atrial Appendage Occlusion device offers a trusted alternative to blood thinning medication for individuals with Non-Valvular AFib (NVAF) who are at an increased risk of stroke. Typically performed in less than an hour, the Left Atrial Appendage Occlusion device closes an area of the heart known as the Left Atrial Appendage (LAA). The LAA is a tube-like sac that creates an environment for clots to form within the heart, heightening the risk of stroke. The Left Atrial Appendage Occlusion device reduces both stroke risk and bleeding risk while allowing patients to ultimately stop taking their blood thinning medication.

There are many reasons an individual may not be able to tolerate blood thinning medication. These include, but are not limited to, those with: a history of bleeds, high risk of recurrent falls, an occupation or lifestyle that makes them a poor candidate for blood thinning medication, severe renal failure, or documented poor adherence which can be due to side effects or the financial burden of life-long blood thinners. To find out if you are a candidate for the Left Atrial Appendage Occlusion procedure today, please contact Kylie Debias, Structural Heart Coordinator, at (814) 534-1548 or kmdebias@conemaugh.org.

“Having the Watchman procedure was one of the best decisions I ever made,” shared Ralph Wilson, a Watchman patient at Conemaugh. The cost of being on blood thinners was getting high and now I do not have to worry about blood clots causing a stroke. Now that I am off my blood thinners, I can lead an active lifestyle and enjoy hunting and camping, without worrying about the possibility of bleeding if an injury occurs.”

"I have been treating Ralph for atrial fibrillation since 2016," Dr. Mastrine added, "It was very gratifying to see his relief after stopping his blood thinners and avoiding the long-term risks of significant bleeding.”

TAVR

INFORMATION COMING SOON.